每日一文(May 2001)

May 31, 2001 Percutaneous In Situ Coronary Venous Arterialization
...We report the use of a catheter-based system for arterializing the adjacent anterior cardiac vein in a patient with chronic total occlusion of the left anterior descending coronary artery...
May 30, 2001 mRNA turnover
Nuclear RNA-binding proteins can record pre-mRNA processing events in the structure of messenger ribonucleoprotein particles (mRNPs).
May 29, 2001 International standards in laboratory medicine
International standards play an important role in establishing quality systems. A considerable number of standards have been created by ISO and CEN for medical laboratories. Standards can be looked upon in a hierarchal manner but most standards are produced in similarly with iterative consultations and review by the intended users.
May 28, 2001 Switch-based mechanism of kinesin motors
Kinesin motors are specialized enzymes that use hydrolysis of ATP to generate force and movement along their cellular tracks, themicrotubules.
May 27, 2001 Beyond Insomnia: Strategies of Circadian Genomics
With people flying across time zones in ever-increasing numbers, jet lag is attracting lots of attention. In fact, research on biological rhythms is now a hot area in genomics.
May 26, 2001 APOPTOSIS:Death of a Monopoly?
Programmed cell death (PCD, also called apoptosis or physiological cell death), a common and evolutionarily conserved property of all metazoans, is an essential part of life. In many fundamental biological processes such as development and the strictly regulated cellular homeostasis, PCD is required to eliminate unwanted and supernumerary cells.
May 25, 2001 The Discovery of Type 1 Diabetes
The etiological heterogeneity of idiopathic diabetes has been recognized for 25 years, and subdivision into type 1 and type 2 diabetes is fundamental to the way we think about the disease.
May 24, 2001 Biomarkers for Early Detection of Colon Cancer
There is an increasing demand for biomarkers in colon cancer for risk assessment, early detection, prognosis, and surrogate end points.
May 23, 2001 Control of a Genetic Regulatory Network by a Selector Gene
The formation of many complex structures is controlled by a special class of transcription factors encoded by selector genes.
May 22, 2001 Whole-cell simulation: a grand challenge of the 21st century
Study of the cell will never be complete unless its dynamic behavior is understood. The complex behavior of the cell cannot be determined or predicted unless a computer model of the cell is constructed and computer simulation is undertaken.
May 21, 2001 Proteomics: a technology-driven and technology-limited discovery science

An emerging field for the analysis of biological systems is the study of the complete protein complement of the genome, the ‘proteome’. There are several complementary tools available for proteome analysis including...

May 20, 2001 Continuous recycling: a mechanism for modulatory signal transduction
Modulatory signal transduction commonly requires efficient ‘on demand’assembly of specific multicomponent cellular machines that convert signals to cellular actions. This article suggests that for these signaling machines to detect and respond to fluctuations in signal strength, they must be continuously disassembled in an energy-dependent process that probably involves molecular chaperones.
May 19, 2001 DISCOVERY(April 2001) - our genome’s geography
Obesity Gene, Dangerous Beauty, Protein Fights HIV, Human Genome Sequenced, Stories from the Genome, SNP Map, Rett Syndrome.
May 18, 2001 The Nuclear Pore Complex as a Transport Machine
Eukaryotic cells separate the nuclear synthesis of DNA and RNA from cytoplasmic protein synthesis with a barrier termed the nuclear envelope (NE). The NE is perforated by large proteinaceous assemblies, called nuclear pore complexes (NPCs), which act as the sole gatekeepers controlling the exchange of material between the two locales.
May 17, 2001 The case of CO signaling: why the jury is still out
CO is a signaling agent cite circumstantial evidence: CO is synthesized in vivo by heme oxygenase (HO), HO colocalizes with soluble guanylate cyclase (sGC) in numerous brain regions (2), and HO knockout mice demonstrate enteric dysfunction.
May 16, 2001 The impact of the Human Genome Project on medical genetics
The near completion of the Human Genome Project stands as a remarkable achievement, with enormous implications for both science and society.
May 15, 2001 Computing Comes to Life
Biologists and computer scientists have designed digital logic gates based on the metabolism of living cells, with the aim of eventually building a computer out of colonies of Escherichia coli or some other single-celled organism.
May 14, 2001 The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity
Both clinical and animal studies suggest that therapeutic strategies that have mainly focused on the use of CD8+ T cells (and MHC class I-restricted tumor antigens) are not effective in eliminating cancer cells. Recent interest has been directed towards the use of CD4+ T cells in generating antitumor immunity.
May 13, 2001 The parts list of life
The genome has turned out to be a relatively poor source of explanation for the differences between cells or between people.
May 12, 2001 Molecular targets for breast cancer therapy and prevention
The recent completion of the human genome sequence has raised great hopes for the discovery of new breast cancer therapies based on newly-discovered genes linked to breast cancer development and progression. Here we describe breast cancer therapies that have emerged from gene-based scientific efforts over the past 20 years and that are now approved for clinical testing or treatment.
May 11, 2001 Breast cancer genetics: What we know and what we need
Unanswered questions include the number and nature of genetic variants that predispose women to breast cancer, the interplay between those variants and environmental factors, and the optimal use of that information to reduce both the personal and social costs of breast cancer.
May 10, 2001 Journal impact factors: a `bioequivalence' issue?
Journal impact factors (IMFs) are used increasingly by institutions as performance indicators of the quality of `individual research output'.
May 9, 2001 Gene transfer of antisense hypoxia inducible factor-1 a enhances the therapeutic efficacy of cancer immunotherapy
Solid tumors meet their demands for nascent blood vessels and increased glycolysis, to combat hypoxia, by activating multiple genes involved in angiogenesis and glucose metabolism.
May 8, 2001 The Mitochondrion: Is It Central to Apoptosis?
Researchers studying apoptosis are divided into two camps. At issue: whether the mitochondria or enzymes called caspases are primary in triggering programmed cell death.
May 7, 2001 Differentiation of Embryonic Stem Cell Lines Generated from Adult Somatic Cells by Nuclear Transfer
ntES cells contributed to an extensive variety of cell types, including dopaminergic and serotonergic neurons in vitro and germ cells in vivo.
May 6, 2001 Molecular markers predictive of response to chemotherapy in gastrointestinal tumors
Gastrointestinal cancers account for a large amount of human tumors. Surgery is the standard treatment for localized gastrointestinal cancer, but in a large number of patients, tumors are unresectable at time of diagnosis and even when resectable, survival is often poor.
May 5, 2001 Molecular Analyses of Oral Polio Vaccine Samples
The “OPV/AIDS hypothesis” suggests that the OPV used in this campaign was produced in chimpanzee kidney epithelial cell cultures rather than in monkey kidney cell cultures.
May 4, 2001 The many ways to cross the plasma membrane
The which monitor or modify molecule-specific intracellular processes, provides an efficient way to study the temporal and spatial regulation of protein systems that underlie basic cellular functions.
May 3, 2001 Postgenomic technologies: hunting the genes for common disorders
The publication of a draft sequence of 90% of the human genome heralds an exciting era in human genetics research. In the past 20 years, efforts have focused on mapping and cloning the genes for about 1000 human genetic disorders.
May 2, 2001 Gearing up for the post-genome world
To deliver on the promise of the genome, scientists are developing highthroughput tools, and the tools themselves are fueling a revolution in biology.
May 1, 2001 Do Centrosome Abnormalities Lead to Cancer?
Evidence suggests that at least some cancers arise because centrosome malfunction causes chromosome damage and missorting.

更新于2001-05-31